Interspecies scaling: Predicting clearance of anticancer drugs in humans. A comparative study of three different approaches using body weight or body surface area

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 21, Issue 3, 1996, Pages 275-278

  Mahmood, I ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Anticancer drugs; Body surface area; Body weight; Man; Predicting clearance

Indexed keywords

ACIVICIN; AMSACRINE; ANTINEOPLASTIC AGENT; ASULACRINE ISETHIONATE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; METHOTREXATE; QUINONE DERIVATIVE;

ALLOMETRY; ARTICLE; BODY SIZE; BODY WEIGHT; COMPARATIVE STUDY; DRUG CLEARANCE; HUMAN; NONHUMAN; PREDICTION; SPECIES DIFFERENCE;

EID: 0030448841     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189726     Document Type: Article

References (18)

1. Heusner A.A. (1987) : What does the power function reveal about structure and function in animals of different size. Annu. Rev. Physiol., 78, 121-133.
2. McNamara P.J. (1991) . Interspecies scaling in pharmacokinetics. In: Welling P.G., Tse F.L.S., Dighe S.V. (Eds) Pharmaceutical Bioequivalence. New York, Marcel Dekker, pp. 267-300.
3. Boxenbaum H., Murray W., Markin, R., Ciraulo D. (1985) : In: Barnett G., Nora C.C. (Eds) Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs. Forest City, CA, USA, Biomedical Publications, p. 93.
4. Voisin E.M., Ruthsatz M., Collins J.M., Hoyle P.C. (1990) : Extrapolation of animal toxicity to humans: interspecies comparisons in drug development. Reg. Toxicol. Pharmacol., 12, 107-116
5. Chappel W.R., Mordenti J. (1991) : Extrapolation of toxicological and pharmacological data from animals to humans. Adv. Drug. Res., 20, 1-116.
6. Boxenbaum H. (1984) : Interspecies pharmacokinetic scaling and the evolutionary comparative paradigm. Drug Metab. Rev., 15, 1071-1121.
7. Dedrick R.L., Forrester D.D., Cannon J.N., Dareer S.M E., Mellett B.L. (1973) : Pharmacokinetics of 1-β-D-arabinofuranosylcytosine (Ara-C) deamination in several species. Biochem. Pharmacol., 22, 2405-2417.
8. King F.G., Dedrick R.L, Farris F.F. (1986) : Physiological pharmacokinetic modeling of cis-dichlorodiamineplatinum (II) (DDP) in several species. J. Pharmacokinet. Biopharm., 14, 131-155.
9. Paxton J.W., Kim S.N , Whitfield L R. (1990) : Pharmacokinetic and toxicity of the antitumor agents amascrine and CI-921, a new analogue, in mice, rats, rabbits, dogs and humans. Cancer Res., 50, 2692-2697.
10. McGovern P.J., Williams M.G., Stewart J.C. (1988) : Interspecies comparison of acivicin pharmacokinetics. Drug. Metab. Dispos., 16, 18-22.
11. Kaye S.B., Workman P., Graham P.A., Cassidy J., Jorell D. (1993) : Pharmacokinetics and early clinical studies of selected new drugs. In: Workman P., Graham M.A. (Eds) Pharmacokinetics and Cancer Chemotherapy. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, pp. 371-396.
12. Mehta S.C., Lu D.R. (1995) : Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans. Biopharm. Drug. Dispos., 16, 735-744.
13. Sacher G. (1959) : Relation of lifespan to brain weight and body weight in mammals. In: Wolstenholme G.E.W , O'Connor M. (Eds) CIBA Foundation Colloquium on Aging. London, Churchill, pp. 115-133.
14. Derrick R.L., Bischoff K.B., Zaharko D.Z. (1970) : Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother. Rep , Part 1, 54, 95-101.
15. Mordenti J. (1986) : Man versus beast. J. Pharm. Sci., 75, 1028-1040.
16. Boxenbaum H (1982) : Interspecies scaling, allometry, physiological time and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm., 10, 201-227.
17. Dedrick R.L. (1973) : Animal scale-up. J. Pharmacokinet. Biopharm., 1, 435-461.
18. Kleiber M. (1961): In: The Fire of Life, an Introduction to Animal Energetics. New York, Wiley.